Opus Genetics, Inc. — SC 13G Filings
13 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Opus Genetics, Inc. (IRD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Opus Genetics, Inc. has filed 13 SC 13G documents with the SEC since 2003. To view all SEC filings by Opus Genetics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10KSB
10QSB
144
25
3
4
4/A
424A
424B3
424B4
424B5
425
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PRE 14C
PREC14A
PRER14A
PRER14C
PRRN14A
PX14A6G
REGDEX
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | SCHEDULE 13G | 0001213900-22-027670 | May 17, 2022 | — |
| SC 13G | SC 13G | 0000897101-21-000241 | Mar 26, 2021 | — |
| SC 13G | SC 13G | 0001140361-21-008779 | Mar 17, 2021 | — |
| SC 13G | THE SCHEDULE 13G | 0000921895-20-002997 | Nov 16, 2020 | — |
| SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-20-010003 | Nov 16, 2020 | — |
| SC 13G | EMPERY ASSET MANAGEMENT, LP | 0000902664-20-003898 | Nov 12, 2020 | — |
| SC 13G | — | 0000919574-20-004951 | Aug 10, 2020 | — |
| SC 13G | — | 0000919574-19-000760 | Feb 5, 2019 | — |
| SC 13G | SC 13G | 0001193125-18-310598 | Oct 29, 2018 | — |
| SC 13G | SC 13G | 0001104659-18-064080 | Oct 26, 2018 | — |
| SC 13G | SABBY 13G RNN 2.29.16 | 0001535610-16-000141 | Feb 29, 2016 | — |
| SC 13G | REXAHN PHARMACEUTICALS, INC. | 0000902664-15-004129 | Nov 10, 2015 | — |
| SC 13G | SABBY 13G RNN 12.4.12 | 0001535610-12-000022 | Dec 4, 2012 | — |